Journal of Family Medicine and Primary Care · 2020 · 46 citations · 22 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceDiagnostic MicrobiologyMedical MicrobiologyAntibacterial AgentsAntibacterial ResistanceAntibiotic ProductionAntimicrobial Susceptibility TestingBeta-lactam ResistanceResistance In Gram-negative BacteriaAmpc Beta-lactamase-mediated ResistanceAmpc Beta-lactamasesAntimicrobial Resistance In Urinary Tract InfectionsExtended-spectrum Beta-lactamase Producing OrganismsExtended-spectrum Beta-lactamase ProductionExtended-spectrum Beta-lactamase-producing OrganismsMinimum Bactericidal ConcentrationMinimum Inhibitory Concentration Testing
INTRODUCTION: ) against extended-spectrum beta-lactamase (ESBL), metallo-beta-lactamase (MBL), and AmpC beta-lactamase-producing gram-negative bacteria causing urinary tract infection. METHODS: ) for its antibacterial activity. RESULTS: species with 19 mm zone of inhibition, 0.39 mg/ml minimum inhibitory concentration (MIC) and 0.19 mg/ml minimum bactericidal concentration (MBC). CONCLUSIONS: Clove extract showed different antibacterial potential against all gram-negative uropathogens. Clove activity for particular strain was found to be similar between isolates producing beta-lactamase and non beta-lactamase.
22
Safar Farajnia, Mohammad Yousef Alikhani, Reza Ghotaslou et al. · International Journal of Infectious Diseases · 2008 · 231 citations · Full text